Ensysce Biosciences (ENSCW) Tax Provisions (2018 - 2021)

Ensysce Biosciences (ENSCW) has 4 years of Tax Provisions data on file, last reported at -$61278.0 in Q1 2021.

• Tax Provisions for Q1 2021 came in at -$61278.0, down 182.11% year-over-year; the trailing twelve-month figure through Mar 2021 was $128741.0 (down 69.14% YoY), and the FY2020 annual result was $244493.0, down 56.1% from the prior year.
• Tax Provisions eased to -$61278.0 in Q1 2021 per ENSCW's latest filing, from $74625.0 in the prior quarter.
• Over five years, Tax Provisions peaked at $227214.0 in Q2 2019 and troughed at -$61278.0 in Q1 2021.
• A 4-year average of $112422.7 and a median of $121450.5 in 2018 frame the typical range for Tax Provisions.
• The sharpest annual moves came in 2019 and 2021: Tax Provisions soared 89.5% in 2019, then sank 182.11% in 2021.
• A 4-year view of Tax Provisions shows it stood at $180890.0 in 2018, then plunged by 44.12% to $101076.0 in 2019, then dropped by 26.17% to $74625.0 in 2020, then slumped by 182.11% to -$61278.0 in 2021.
• Business Quant data shows ENSCW's Tax Provisions at -$61278.0 in Q1 2021, $74625.0 in Q1 2020, and $101076.0 in Q4 2019.